About this trial
This study looks at two ways to manage pain for patients after surgery to remove lymph nodes due to testicular cancer. Doctors want to see how effective intrathecal morphine and intravenous methadone are for pain relief in the first 24 hours after surgery. Both treatments are standard care, and the study will measure how well they work at different times after the operation.
The trial's ID number is NCT06593665. It is a Phase 3 trial, which means it is looking at how well the treatments work and how safe they are. The trial is FDA-regulated and aims to include 142 participants.
Who can join
Men aged 18 to 80 who are having surgery for testicular cancer and have not received chemotherapy can join. Certain health conditions, allergies to the study drugs, or recent substance abuse may prevent someone from participating. The trial team will confirm if each person is eligible.
Condition
Testicular Cancer
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into two groups. One group will receive intrathecal morphine, and the other will receive intravenous methadone during their surgery. Both treatments will be given alongside standard pain management methods.
Where
This trial is running at 2 locations in the United States. All of them are currently recruiting.
Indiana Univeristy
Indianapolis, Indiana
Indiana University Hospital
Indianapolis, Indiana